Ind-Swift Laboratories Ltd (INDSWFTLAB) — FY26 Annual Report | 5 September 2026

Ind-Swift Laboratories Ltd submitted its FY2025-26 annual report on 2026-09-05, confirming a pure-play formulation reset, zero net debt, and strong pipeline momentum. The filing highlights 45 pipeline products, 15 new launches, 69 regulatory approvals, and 85 global markets served. Key financials show operating EBITDA of ₹44.78 crores for FY26 with a 7.04% margin, while Q1 FY27 operating EBITDA margin surged to 17.91%. The company held 10 board meetings, all attended, with no material changes or insolvency concerns. Shareholder communications include AGM on 2026-09-30 via VC, paid BSE/NSE listing fees, and ₹252.30 Lakhs CSR spend with ₹12.09 Lakhs excess.